Home › Funds › MPM BioImpact LLC › NTRA

MPM BioImpact LLC position in NTRA

NATERA INC · Health Care

MPM BioImpact LLC reported holding 92,638 shares of NTRA (NATERA INC) in its Q2 2026 13F filing — a position valued at US$25.1M, representing 1.53% of its reported portfolio and ranking #25 among its reported holdings. MPM BioImpact LLC has disclosed NTRA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)92.64K sh
Reported value held$25.15M
Portfolio Weight1.53%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MPM BioImpact LLC's NTRA position evolved

MPM BioImpact LLC first disclosed a stake in NTRA in Q1 2024 at 172,413 shares (US$15.8M). The position peaked in Q4 2024 at 160,626 shares, worth US$25.4M. Across 10 filings, MPM BioImpact LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 92,638 shares valued at US$25.1M. Notable position changes include a 37% trim in Q2 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 172.41K $15.77M New
Q2 2024 174.81K $18.93M Add
Q3 2024 177.10K $22.48M Add
Q4 2024 160.63K $25.43M Reduce
Q1 2025 157.05K $22.21M Reduce
Q2 2025 98.92K $16.71M Reduce
Q3 2025 98.92K $15.92M Hold
Q4 2025 93.55K $21.43M Reduce
Q1 2026 93.07K $18.61M Reduce
Q2 2026 92.64K $25.15M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NTRA and 13F data

NTRA (NATERA INC) is a Health Care company. 52 other funds we track also report a position in NTRA — the largest reported positions include JPMorgan Chase & Co (US$3.51B), Duquesne Family Office LLC (US$864.9M), Castle Hook Partners LP (US$704.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NTRA

All NTRA fund holders →

FAQ

How long has MPM BioImpact LLC held NTRA?

MPM BioImpact LLC has disclosed NTRA holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is MPM BioImpact LLC's current position in NTRA?

As of Q2 2026, MPM BioImpact LLC holds 92.64K shares of NTRA (NATERA INC), valued at $25.15M, representing 1.53% of its reported portfolio and ranking #25.

Has MPM BioImpact LLC been buying or selling NTRA?

In the latest 13F filing (Q2 2026), MPM BioImpact LLC held unchanged its position in NTRA. The position peaked in Q4 2024 at 160.63K shares.

Which other funds hold NTRA?

Other major institutional holders of NTRA include JPMorgan Chase & Co, Duquesne Family Office LLC, Castle Hook Partners LP, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.